A whistle-blower who alleges that medicines made in India are unsafe is now suing the Indian government to force it to better regulate its pharmaceuticals industry. Health economist Peter Berman of Harvard T.H. Chan School of Public Health agrees that something must be done.
“It’s a very significant issue and it is something that needs to be addressed in India and some kind of legal action is appropriate,” said Berman, professor of the practice of global health systems, in a March 8, 2016 Bloomberg article.
The Indian government is being sued by Dinesh Thakur, who worked for more than 20 years at U.S. and Indian pharmaceutical companies. Thakur previously helped the U.S. government win a $500 million settlement against the generic-drug company Ranbaxy for systemic product-testing failures.
Read the Bloomberg article: Whistle-Blower of Unsafe Medicines Takes on ‘Made in India’